The University of Chicago Header Logo

Connection

Daniel S. Rubin to Bevacizumab

Back to Details
This is a "connection" page, showing publications Daniel S. Rubin has written about Bevacizumab.
Daniel S. Rubin
Connection Strength
0.044
Bevacizumab
  1. Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration. Transl Vis Sci Technol. 2021 06 01; 10(7):30.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.